PROMOTION AND ADOPTION OF SCREENING STRATEGIES IMPROVE HEALTH AND REDUCE THE BURDEN OF CANCER, ALLOWING EARLY DIAGNOSIS, TIMELY INTERVENTIONS AND, CONSEQUENTLY, A BETTER PROGNOSIS FOR PATIENTS SUFFERING FROM MALIGNANT TUMOURS.
Each type of screening is tailored to the specific characteristics and risk factors associated with certain types of cancer. By promoting and supporting these screening strategies, we aim to detect cancers at an early stage, when the chances of successful treatment and care are generally greater.
Mammography for the early detection of breast cancer. Mammography is a radiological test that allows you to identify any anomalies or early signs of breast cancer.
Prostate-specific antigen (PSA)-based tests for early detection of prostate cancer. The PSA test measures the levels of an antigen produced by the prostate, which may be elevated in the presence of prostate cancer.
Fecal occult blood tests, colonoscopy and sigmoidoscopy. The test is a non-invasive test that allows you to identify the presence of occult blood in the stool, potentially indicative of intestinal tumors. Colonoscopy and sigmoidoscopy are endoscopic tests that allow you to directly visualize the inside of the colon and identify any polyps or tumors.
Low-dose computed tomography for high-risk smokers. This imaging technique helps identify any lesions or nodules in the lung that could be indicative of lung tumors.
Mole mapping to identify any changes or suspicious signs of skin cancer. This type of screening aims to detect melanoma and other types of skin cancer early.
HPV test for the detection of the human papilloma virus, which is responsible for the development of cervical cancer. This type of screening can help detect high-risk HPV infections that can lead to precancerous lesions or cervical cancer.
Gastroscopy to detect precancerous lesions or early gastric cancer, particularly in areas with high incidence or with important family history.